Zynlonta Prices, Coupons, Copay Cards & Patient Assistance
Zynlonta (loncastuximab tesirine) is a member of the miscellaneous antineoplastics drug class and is commonly used for Diffuse Large B-Cell Lymphoma.
The cost for Zynlonta lpyl 10 mg intravenous injection is around $29,651 for a supply of 1 injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Zynlonta prices
Intravenous Injection
lpyl 10 mg
Zynlonta intravenous injection
from $29,651.19
for 1 injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $29,651.19 | $29,651.19 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Zynlonta Coupons, Copay Cards and Rebates
Zynlonta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Zynlonta Advancing Patient Support Copay Assistance Program
Eligible commercially insured patients may pay $0 per dose up to a maximum benefit of $25,000 per calendar year.
- Applies to:
- Zynlonta
- Number of uses:
- per prescription per calendar year
Form more information phone: 855-690-0340 or Visit website
Patient Assistance & Copay Programs for Zynlonta
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Zynlonta (loncastuximab tesirine-lpyl) Injection; IV
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Zynlonta (loncastuximab tesirine-lpyl) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Advancing Patient Support: Zynlonta
Eligibility requirements:- Determined case by case
- Based on FPL
- Medically Necessary as determined by a Doctor
- Must be a US resident and treated by a US licensed healthcare provider
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Zynlonta (loncastuximab tesirine-lpyl) Injection; IV
More information please phone: 855-690-0340 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Lunsumio
Lunsumio (mosunetuzumab-axgb) is used for the treatment of relapsed or refractory follicular ...
More about Zynlonta (loncastuximab tesirine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
